Reviva grants stock options to CEO, CFO, and VP; 1.303M shares total

REVIVA PHARMACEUTICALS HOLDINGS, INC.

CEO Dr. Bhat granted option for 443,000 shares; CFO Prabhu for 170,000 shares.
VP Seema Bhat (CEO's spouse) granted option for 150,000 shares.
Options vest 50% immediately, then 1.389% monthly; exercise price $6.74.
Additional 540,000 options awarded to other employees under 2020 Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.